9-L-beta-Aspartic acid daptomycin is a cyclic peptide compound used as an active pharmaceutical ingredient (API) in pharmaceutical manufacturing. It is structurally related to antimicrobial peptides that form part of the innate immune response and are studied for their broad-spectrum antimicrobial potential.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 9-L-beta-Aspartic acid daptomycin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
(2R)-daptomycin
pharmaceutical raw material
Daptomycin, 9-(2,5-dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine-
pharmaceutical raw material
Abemaciclib
pharmaceutical raw material
Abemaciclib mesylate
pharmaceutical raw material
Ganirelix
pharmaceutical raw material
Clofarabine
pharmaceutical raw material
(3S,6S,9R,16S,19R,22S,25S,31S,32R)-31-[[(2S)-2-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-3-[2-(2-aminophenyl)-2-oxoethyl]-25-(3-aminopropyl)-22-(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-19,32-dimethyl-2,5,8,11,14,18,21,24,27,30-decaoxo-1-oxa-4,7,10,13,17,20,23,26,29-nonazacyclodotriacontane-16-carboxylic acid
UPYJMYPKAJFHRN-QCMAZARJSA-N
CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)C(=O)O)CO)[C@H](C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C
Sourcing 9-L-beta-Aspartic acid daptomycin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.